Gemcitabine plus enzastaurin or single-agent gemcitabine in locally advanced or metastatic pancreatic cancer: Results of a Phase II, randomized, noncomparative study

Author： Richards Donald   Kuefler Paul   Becerra Carlos   Wilfong Lalan   Gersh Robert   Boehm Kristi   Zhan Feng   Asmar Lina   Myrand Scott   Hozak Rebecca   Zhao Luping   Gill John   Mullaney Brian   Obasaju Coleman   Nicol Steven  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.29, Iss.1, 2011-02, pp. : 144-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer

By El-Rayes Basil   Zalupski Mark   Shields Anthony   Ferris Ann   Vaishampayan Ulka   Heilbrun Lance   Venkatramanamoorthy Raghu   Adsay Volkan   Philip Philip  

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer

By El-Rayes Bassel   Philip Philip   Sarkar Fazlul   Shields Anthony   Ferris Ann   Hess Kenneth   Kaseb Ahmad   Javle Milind   Varadhachary Gauri   Wolff Robert   Abbruzzese James  

Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. : 694-699

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study

By Karasek Petr   Skacel Tomas   Kocakova Ilona   Bednarik Otakar   Petruzelka Lubos   Melichar Bohuslav   Bustova Ivana   Spurny Vladimir   Trason Tomas  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 581-586

Informa Healthcare

Access to resources Recommend Favorite

Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer: A Phase II Study

By Aristides Polyzos  

Clinical Drug Investigation, Vol. 24, Iss. 11, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma

By Ko Andrew  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1597-1606

Springer Publishing Company

Access to resources Recommend Favorite